Non-biological surgical sealant independent of blood coagulation of patients AQUABRID® commences clinical use in Taiwan.
- 2022/03/01 News
Sanyo Chemical Industries, Ltd. (Head Office: Higashiyama ku, Kyoto; President and CEO: Akinori Higuchi; hereinafter “Sanyo Chemical”) announces that AQUABRID local brand name: Hydrofit ® has obtained regulatory approval* as a medical device in Taiwan and clinical use commenced in December 2021. AQUABRID is a non absorbent topical hemostatic sealant for the central circulatory system manufactured by Sanyo Chemical and marketed by Terumo Corporation, a medical device manufacturer , (Head Office: Shibuya ku, Tokyo; CEO:Shinjiro Sato).